Does ABIRATERONE Cause Gait inability? 48 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 48 reports of Gait inability have been filed in association with ABIRATERONE (Abiraterone Acetate). This represents 0.1% of all adverse event reports for ABIRATERONE.
48
Reports of Gait inability with ABIRATERONE
0.1%
of all ABIRATERONE reports
7
Deaths
18
Hospitalizations
How Dangerous Is Gait inability From ABIRATERONE?
Of the 48 reports, 7 (14.6%) resulted in death, 18 (37.5%) required hospitalization, and 1 (2.1%) were considered life-threatening.
Is Gait inability Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ABIRATERONE. However, 48 reports have been filed with the FAERS database.
What Other Side Effects Does ABIRATERONE Cause?
Death (5,623)
Fatigue (1,928)
Drug ineffective (1,732)
Therapy cessation (1,602)
Prostatic specific antigen increased (1,581)
Disease progression (1,098)
Hospitalisation (1,034)
Hot flush (989)
Asthenia (891)
Off label use (859)
What Other Drugs Cause Gait inability?
ADALIMUMAB (3,844)
ETANERCEPT (2,710)
METHOTREXATE (2,559)
TOFACITINIB (2,227)
SECUKINUMAB (2,216)
TOCILIZUMAB (2,139)
LEFLUNOMIDE (2,065)
RITUXIMAB (2,028)
ABATACEPT (2,019)
HYDROXYCHLOROQUINE (1,881)
Which ABIRATERONE Alternatives Have Lower Gait inability Risk?
ABIRATERONE vs ABIRATERONE\ABIRATERONE
ABIRATERONE vs ABOBOTULINUMTOXINA
ABIRATERONE vs ABRAXANE
ABIRATERONE vs ABROCITINIB
ABIRATERONE vs ACALABRUTINIB